Impax Laboratories, Inc. (Nasdaq: IPXL) provided an update and additional information to patients, physicians and customers on its epinephrine injection ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Management Comments

Impax Provides Update on Epinephrine Injection, USP Auto-InjectorAugust 30, 2016 8:02 AM Mylan to launch generic EpiPen at half the price of originalAugust 29, 2016 6:28 AM Impax Laboratories, Inc. Issues Voluntary, Nationwide Recall for One Lot of Lamotrigine Orally Disintegrating Tablet 200 mg Due to the Potential for 100 mg Blister Cards being Packaged in 200 mg ContAugust 26, 2016 6:30 PM